Vivos Therapeutics (VVOS) Receivables - Net (2019 - 2026)
Vivos Therapeutics (VVOS) reported Receivables - Net of $1.8 million for Q1 2026, up 146.38% year-over-year from $718000.0 in Q1 2025, and up 11.89% on a QoQ basis from $1.6 million in Q4 2025.
Vivos Therapeutics (VVOS) has 8 years of Receivables - Net data on file, last reported at $1.8 million in Q1 2026.
- Quarterly Receivables - Net rose 146.38% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (up 146.38% YoY) and the FY2025 annual result came in at $1.6 million, up 267.67% from the prior year.
- Receivables - Net advanced to $1.8 million in Q1 2026 per VVOS's latest filing, from $1.6 million in the prior quarter.
- Across five years, Receivables - Net topped out at $2.1 million in Q3 2025 and bottomed at $202000.0 in Q4 2023.
- The 5-year median for Receivables - Net is $525000.0 (2024), against an average of $813705.9.
- The widest annual swing landed in 2022, when Receivables - Net tumbled 77.41%; it then jumped 370.04% in 2025.
- Tracing VVOS's Receivables - Net over 5 years: stood at $457000.0 in 2022, then sank by 55.8% to $202000.0 in 2023, then soared by 112.87% to $430000.0 in 2024, then surged by 267.67% to $1.6 million in 2025, then increased by 11.89% to $1.8 million in 2026.
- Per Business Quant, the three latest VVOS Receivables - Net figures stand at $1.8 million (Q1 2026), $1.6 million (Q4 2025), and $2.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos Therapeutics | 9.87 Mn | 7.64 Mn | 3.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.77 Mn |
| Mar 31, 2026 | 1.77 Mn |
| Dec 31, 2025 | 1.58 Mn |
| Dec 31, 2025 | 1.58 Mn |
| Sep 30, 2025 | 2.13 Mn |
| Sep 30, 2025 | 2.13 Mn |
| Jun 30, 2025 | 1.63 Mn |
| Jun 30, 2025 | 1.63 Mn |
| Mar 31, 2025 | 718,000.00 |
| Mar 31, 2025 | 718,000.00 |
| Dec 31, 2024 | 430,000.00 |
| Dec 31, 2024 | 430,000.00 |
| Sep 30, 2024 | 454,000.00 |
| Sep 30, 2024 | 454,000.00 |
| Jun 30, 2024 | 395,000.00 |
| Jun 30, 2024 | 395,000.00 |
| Mar 31, 2024 | 525,000.00 |
| Mar 31, 2024 | 525,000.00 |
| Dec 31, 2023 | 202,000.00 |
| Dec 31, 2023 | 202,000.00 |
| Sep 30, 2023 | 228,000.00 |
| Sep 30, 2023 | 228,000.00 |
| Jun 30, 2023 | 327,000.00 |
| Jun 30, 2023 | 327,000.00 |
| Mar 31, 2023 | 321,000.00 |
| Mar 31, 2023 | 321,000.00 |
| Dec 31, 2022 | 457,000.00 |
| Dec 31, 2022 | 457,000.00 |
| Sep 30, 2022 | 866,000.00 |
| Sep 30, 2022 | 866,000.00 |
| Jun 30, 2022 | 791,000.00 |
| Jun 30, 2022 | 791,000.00 |
| Mar 31, 2022 | 1.00 Mn |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 1.20 Mn |
| Dec 31, 2021 | 1.20 Mn |
| Sep 30, 2021 | 3.83 Mn |
| Sep 30, 2021 | 3.83 Mn |
| Jun 30, 2021 | 3.46 Mn |
| Jun 30, 2021 | 3.46 Mn |
| Mar 31, 2021 | 1.66 Mn |
| Mar 31, 2021 | 1.66 Mn |
| Dec 31, 2020 | 1.43 Mn |
| Dec 31, 2020 | 1.43 Mn |
| Dec 31, 2019 | 871,290.00 |
| Dec 31, 2019 | 871,290.00 |